U.S. Orthopedic Devices Market Size, Share & COVID-19 Impact Analysis, By Type (Joint Reconstruction Devices {Knee, Hip, and Extremities}, Spinal Devices {Spinal Fusion Devices, and Spinal Non-fusion Devices}, Trauma Devices, Orthobiologics, Arthroscopy Devices, and Others), By End-user (Hospitals & ASCs, Orthopedic Clinics, and Others), and Country Forecast, 2023-2030

The U.S. orthopedic devices market size was worth USD 28.82 billion in 2022 and is projected to grow at a CAGR of 5.0% during the forecast period. 

Orthopedic devices are designed to manage or prevent musculoskeletal conditions. The growing prevalence of orthopedic disorders, such as rheumatoid arthritis (RA), osteoarthritis, fibromyalgia, and juvenile arthritis, is the major factor driving the growth of the U.S. orthopedic devices market share.

• For instance, according to data published by the American College of Rheumatology, nearly 1.3 million people suffer from rheumatoid arthritis in the U.S., accounting for 0.6 to 1% of the total population in the U.S. In addition, the most common form of arthritis is osteoarthritis (OA), affecting over 32.5 million people in the country.

Furthermore, the rising number of sports-related injuries, rapid growth in the geriatric population, the increasing adoption of minimally invasive surgeries, and the advancements in orthopedic surgeries are the other factors driving the demand for these devices in the U.S.

However, in 2020, the U.S. orthopedic devices industry was impacted negatively due to the outbreak of COVID-19. Factors, such as lack of workforce & staff, the risk of transmission of COVID-19, and the decline in orthopedic procedures hampered market growth.

LATEST TRENDS

Rising Demand for Minimally Invasive Orthopedic Surgical Procedures 

Minimally invasive surgical procedures have gained significant momentum in the orthopedic segment with faster recovery duration, reduced bleeding and scars, better clinical outcomes, and decreased postoperative complications and hospital stays. The rising incidence of orthopedic diseases has led to the expansion of minimally invasive surgeries, mostly in the aging population.

Furthermore, prominent companies in the market are focused on expanding their portfolio of robotic-assisted surgery systems through new product launches, merges and acquisitions to expand their position.

• For instance, in April 2023, Orthofix Medical Inc., a manufacturer of spine and orthopedic implants, announced the launch of two access retractor systems to aid surgeons during Minimally Invasive Spine (MIS) procedures. The Lattus Lateral Access System and the Fathom Pedicle-Based Retractor System expand the Company’s offering of access solutions to address the minimally invasive spine surgery market.

DRIVING FACTORS

Rising Prevalence of Musculoskeletal Disorders in Obese Individuals to Augment Market Growth

Obesity has also been associated with the secretion of proinflammatory cytokines and reduction in bone mass. These factors increase the chances of musculoskeletal disorders in obese patients. Obesity has been linked to the pathophysiology of osteoarthritis, osteoporosis, fractures, and numerous soft tissue disorders. Factors, such as sedentary lifestyle, ageing population, obesity, and a higher incidence of work-related injuries is increasing the incidence and prevalence of musculoskeletal disorders

• For instance, according to the data published by World Health Organization (WHO) in March 2022, around 167 million people including adults and children will suffer from obesity by 2025.

Thus, the increasing prevalence of musculoskeletal disorders and awareness among patients about importance of early diagnosis is projected to drive the demand for treatment options, thereby influencing the adoption of these devices.

RESTRAINING FACTORS

Post-Surgical Complications associated with Orthopedic Devices May Hamper Market Growth 

Despite the growing prevalence of orthopedic injuries and a rise in the elderly population, the high cost of orthopedic procedures and post-surgical complications are hampering the demand for the devices. The common post-surgical complications include inflammatory skin reactions, swelling, pain, implant loosening, and occasionally fistula formation.

Furthermore, these reactions may cause orthopedic implant failure, resulting to the need for reoperation. For instance, according to the data published by NCBI, hypersensitivity reactions may be seen in up to one-fourth of patients undergoing orthopedic surgeries. In severe cases, the need for reoperation and removal of these devices may be indicated. These factors might hamper the U.S. orthopedic devices market growth to a certain extent.

Request a Free sample to learn more about this report.

In the U.S., adults aged 40-59 are more likely to suffer from obesity than adults aged 20 to 39 years and above 60 years.

SEGMENTATION

By Type Analysis

Based on type, the U.S. orthopedic devices market is segmented into joint reconstruction devices, trauma devices, spinal devices, orthobiologics, arthroscopy devices, and others.

The joint reconstruction devices segment held a larger share in 2022. The growth was mainly attributed to the demand for minimally invasive diagnostic and surgical techniques in the U.S., growing prevalence of orthopedic conditions, and increasing patient base with growing population. Moreover, the segment is further augmented by the increasing new product launches, collaborations and partnerships among market players aiming to consolidate their market share.

For instance, in July 2022, Enovis launched Arvis, a wearable device for knee and hip replacements.  The device helps orthopedic surgeons with precision guidance visualization while performing hip and knee surgery.

Furthermore, the trauma devices segment is projected to grow significantly by 2030. The segment's growth is mainly attributed to the growing cases of road accidents, the rising generic population who are more prone to osteoarthritic injuries, and increasing awareness of the commercially available advanced devices. In addition, technological advancements, such as product launches, acquisitions, mergers, and partnerships, are influencing the growth of this segment.

• For instance, in February 2023, CurvaFix, Inc., introduced a new intramedullary device for small-boned patients called CurvaFix. The device offers potential benefits in pelvic injuries and conditions, including polytrauma patients with multiple complex injuries. Such product launches are projected to drive segmental growth over the forecast period.

By End-user Analysis

Based on end-user, the U.S. orthopedic devices market is segmented into hospitals & ASCs, orthopedic clinics, and others.

The hospitals & ASCs segment held a highest market share in 2022 owing to the efficient reimbursement policies offered by the hospitals to the patients. addition, the rise in the frequency of road accidents & other sports injuries has resulted in exponential rise in hospitalization, thereby propelling the growth of this segment. This is further driven by skilled professionals for traumatic injuries treatments and the expansion of healthcare settings in the hospitals.

On the other hand, the orthopedic clinics segment held a substantial market share in 2022. The quality of procedures and care, short-duration length of stays, emergence of minimal invasive surgeries and devices are likely to drive the segmental growth in the upcoming years, from 2023-2030.

KEY INDUSTRY PLAYERS

Regarding the competitive landscape, the market consists of several established and emerging players. Stryker dominated the U.S. market in 2022 owing to its robust product portfolio and solid geographical presence. Moreover, the company is actively involved in strategic partnerships, merges, and collaborations to expand its geographical presence.

Other key players with a considerable presence in the U.S. market include NuVasive, Inc., Arthrex Inc., MicroPort Scientific Corporation, Globus Medical, Össur Corporate, and Others. These key players are trying to acquire smaller companies and invest in R&D activities to broaden and strengthen their geographical reach.

• In November 2022, MicroPort Scientific Corporation, a manufacturer of orthopedic devices, announced the expansion of its partnership with Pixee Medical by commercializing its combined surgical solution in the U.S. Such strategic initiatives are expected to strengthen the companies' market presence further.

LIST OF KEY COMPANIES PROFILED:

• Stryker (U.S.)  


• Johnson & Johnson Services, Inc. (U.S)


• Zimmer Biomet (U.S.)


• Smith & Nephew (U.S.)


• Medtronic (Ireland)   


• NuVasive, Inc. (U.S.)


• Arthrex Inc. (U.S.)


• Globus Medical (U.S.)


• Össur Corporate (Iceland)


• Integra LifeSciences (U.S.)

KEY INDUSTRY DEVELOPMENTS: 

• January 2023 - Orthofix Medical Inc., a manufacturer of orthopedics devices, announced the launch Mariner Deformity Pedicle Screw System to provide a comprehensive implant offerings during surgery.


• August 2022 - OSSIO, Inc., a fast-growing orthopedic implant company, announced the U.S. launch of OSSIOfiber Suture Anchors for the use in shoulder, knee, foot/ankle, hand/wrist and elbow surgery.


• January 2021 - Stryker announced the acquisition of OrthoSensor, Inc., a privately held manufacturing musculoskeletal care and sensor technology for total joint replacement. The acquisition aims to expand Stryker's product portfolio for orthopedic devices.

REPORT COVERAGE

An Infographic Representation of U.S. Orthopedic Devices Market

View Full Infographic

To get information on various segments, share your queries with us

The U.S. orthopedic devices market report provides a detailed analysis of the market. It focuses on key industry developments such as mergers, partnerships, & acquisitions, competitive landscape, and the impact of COVID-19 on the market. Besides this, the research report also offers insights into the market trends and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the growth of the market over recent years.

Report Scope & Segmentation